Peter MD review

Peter MD's case is breadth, not a low-dose product: TRT, GLP-1, NAD+, sermorelin, men's hair loss and ED all live under one physician-prescribed account, and every price is published openly on its own site rather than gated behind a quiz. What it does not have, as far as its own product pages show, is a dedicated microdose SKU — the tirzepatide plan states a 60mg dose, which sits in the standard maintenance range rather than a starting-low tier, and the GLP1 + B12 semaglutide plan is priced by first-time-vs-returning status rather than by dose size. For a reader here specifically to start low, that is a real gap worth naming plainly rather than talking around.

No confirmed low-dose or microdose SKU — the tirzepatide plan is a 60mg maintenance-range dose, not a microdose, and the GLP1 + B12 semaglutide tiers are standard plans, not a dedicated start-low product, which is a real fit gap for a reader here specifically to microdose

Peter MD (getpetermd.com) is a physician-prescribed telehealth brand founded in 2021 and headquartered in Miami, FL, selling across TRT, ED, non-GLP-1 weight loss, GLP-1, men's hair loss and NAD+ from a single account. Its GLP-1 line is compounded semaglutide sold as "GLP1 + B12" (Level 1 for first-time users at $149/mo, Level 2 for returning users at $139/mo) and tirzepatide at $149 for the first month then $249/mo billed quarterly at a 60mg dose. That 60mg figure sits in the standard maintenance range rather than a microdose, and neither GLP-1 line is presented on its own product pages as a separately priced low-dose SKU — so there is no confirmed microdose tier to point to here, unlike the handful of rows on this board that do sell one as its own product. The broader catalogue is genuinely wide: Sermorelin, injectable NAD+, and TRT (testosterone cypionate) round out a longevity-and-hormone lineup most single-purpose GLP-1 clinics do not carry. The customer-facing pages state a short excluded-state list per product (e.g., AL/ID on tirzepatide, plus AK/HI on semaglutide), but Peter MD's own affiliate-program disclosures list a longer, treatment-by-treatment set of exclusions — AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX appear somewhere across B-12, tirzepatide, HCG, semaglutide, phentermine, TRT injectables and enclomiphene — so restrictions vary by treatment and are not fully disclosed in one place on the marketing site.

Pricing structure

Varies by dose, plan or tier

Consult

Included in the price

Compounding

Not publicly identified

Labs

Optional

Dietitian support

Not included

• Broad product line under one account — TRT, GLP-1, NAD+, Sermorelin, men's hair loss and ED — so multiple protocols can be managed through a single telehealth relationship
• Physician-prescribed, nationwide telehealth brand with a real operating history (founded 2021, HQ Miami, FL)
• Pricing for every line above is published openly on the provider's own product pages, no quiz required to see a figure

• Price varies by tier and by first-time vs. returning-user status, and the GLP1 + B12 branding means it is not marketed under the generic "semaglutide" name
• State restrictions vary by treatment and are not fully disclosed on the public marketing pages — the affiliate program's own data lists a longer excluded-state set (AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC, TX across different products) than the customer-facing pages show
• Customer reviews are mixed

Intentional GLP-1 microdosing is off-label and unproven — no randomised trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Low dose vs full dose
• What the evidence actually shows
• What microdosing GLP-1 costs
• Titration planner
• Microdose & reconstitution calculator

Peter MD is one of 33 low-dose GLP-1 providers we track. The board lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.